X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-17
TEVA PHARMA
Dec-13
TORRENT PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7682,665-   
Low Rs1,1862,315-   
Sales per share (Unadj.) Rs346.11,529.5-  
Earnings per share (Unadj.) Rs55.295.5-  
Cash flow per share (Unadj.) Rs73.3219.2-  
Dividends per share (Unadj.) Rs14.0083.64-  
Dividend yield (eoy) %0.93.4 28.2%  
Book value per share (Unadj.) Rs257.11,699.0-  
Shares outstanding (eoy) m169.22848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.31.6 262.1%   
Avg P/E ratio x26.826.1 102.7%  
P/CF ratio (eoy) x20.111.4 177.3%  
Price / Book Value ratio x5.71.5 391.9%  
Dividend payout %25.487.5 29.0%   
Avg Mkt Cap Rs m249,8872,111,647 11.8%   
No. of employees `00011.844.9 26.2%   
Total wages/salary Rs m9,9340-   
Avg. sales/employee Rs Th4,971.528,858.6 17.2%   
Avg. wages/employee Rs Th843.20-   
Avg. net profit/employee Rs Th792.41,802.8 44.0%   
INCOME DATA
Net Sales Rs m58,5691,297,049 4.5%  
Other income Rs m2,2330-   
Total revenues Rs m60,8021,297,049 4.7%   
Gross profit Rs m13,773355,198 3.9%  
Depreciation Rs m3,069104,842 2.9%   
Interest Rs m2,05625,476 8.1%   
Profit before tax Rs m10,881224,880 4.8%   
Minority Interest Rs m01,022 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-147,621 0.0%   
Tax Rs m1,545-2,746 -56.3%   
Profit after tax Rs m9,33681,026 11.5%  
Gross profit margin %23.527.4 85.9%  
Effective tax rate %14.2-1.2 -1,163.1%   
Net profit margin %15.96.2 255.2%  
BALANCE SHEET DATA
Current assets Rs m53,841876,022 6.1%   
Current liabilities Rs m31,612763,965 4.1%   
Net working cap to sales %38.08.6 439.3%  
Current ratio x1.71.1 148.5%  
Inventory Days Days9791 107.0%  
Debtors Days Days8496 87.3%  
Net fixed assets Rs m42,079423,645 9.9%   
Share capital Rs m8463,193 26.5%   
"Free" reserves Rs m42,6550-   
Net worth Rs m43,5011,440,775 3.0%   
Long term debt Rs m22,408663,210 3.4%   
Total assets Rs m101,2502,964,172 3.4%  
Interest coverage x6.39.8 64.0%   
Debt to equity ratio x0.50.5 111.9%  
Sales to assets ratio x0.60.4 132.2%   
Return on assets %11.33.6 313.1%  
Return on equity %21.55.6 381.6%  
Return on capital %19.64.9 398.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m14,7620-   
CASH FLOW
From Operations Rs m10,127206,682 4.9%  
From Investments Rs m-7,869-73,236 10.7%  
From Financial Activity Rs m-1,918-247,930 0.8%  
Net Cashflow Rs m212-114,483 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare TORRENT PHARMA With: LUPIN LTD  FULFORD INDIA  CADILA HEALTHCARE  IPCA LABS  PFIZER  



Today's Market

Sensex Opens Marginally Higher; ONGC Rallies 6.3%(09:30 am)

Asian stock markets traded on a mixed note in morning trade as market participants kept an eye on political developments in the U.S. after a government shutdown began last week.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Jan 22, 2018 11:35 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - IPCA LABS COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS